Evgen Pharma plc

United Kingdom

Back to Profile
1-3 of 3 for Evgen Pharma plc Sort by
Query
Aggregations
Jurisdiction
        Canada 1
        World 1
        United States 1
Date
2023 1
2021 2
IPC Class
A61K 31/26 - Cyanate or isocyanate estersThiocyanate or isothiocyanate esters 2
A61P 35/00 - Antineoplastic agents 2
C07C 331/20 - Isothiocyanates having isothiocyanate groups bound to acyclic carbon atoms of a saturated carbon skeleton 2
A61K 47/40 - CyclodextrinsDerivatives thereof 1
A61K 47/69 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit 1
See more
Status
Pending 2
Registered / In Force 1
Found results for  patents

1.

CRYSTALLINE COMPLEXES

      
Application Number 17995617
Status Pending
Filing Date 2021-04-08
First Publication Date 2023-10-12
Owner EVGEN PHARMA PLC (United Kingdom)
Inventor Austin, Talbir Kaur

Abstract

The present invention relates to crystalline complexes of sulforaphane and alpha-cyclodextrin; pharmaceutical compositions comprising the complexes; methods for their manufacture; and the use of said complexes as a medicament.

IPC Classes  ?

  • C07C 331/20 - Isothiocyanates having isothiocyanate groups bound to acyclic carbon atoms of a saturated carbon skeleton
  • A61K 9/16 - AgglomeratesGranulatesMicrobeadlets

2.

CRYSTALLINE COMPLEXES

      
Document Number 03179780
Status Pending
Filing Date 2021-04-08
Open to Public Date 2021-10-14
Owner EVGEN PHARMA PLC (United Kingdom)
Inventor Austin, Talbir Kaur

Abstract

The present invention relates to crystalline complexes of sulforaphane and alpha-cyclodextrin; pharmaceutical compositions comprising the complexes; methods for their manufacture; and the use of said complexes as a medicament.

IPC Classes  ?

  • A61K 31/26 - Cyanate or isocyanate estersThiocyanate or isothiocyanate esters
  • A61K 47/40 - CyclodextrinsDerivatives thereof
  • A61P 35/00 - Antineoplastic agents
  • C07C 331/20 - Isothiocyanates having isothiocyanate groups bound to acyclic carbon atoms of a saturated carbon skeleton
  • C08B 37/16 - CyclodextrinDerivatives thereof
  • C30B 7/02 - Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions by evaporation of the solvent
  • C30B 29/58 - Macromolecular compounds

3.

CRYSTALLINE COMPLEXES

      
Application Number GB2021050861
Publication Number 2021/205171
Status In Force
Filing Date 2021-04-08
Publication Date 2021-10-14
Owner EVGEN PHARMA PLC (United Kingdom)
Inventor Austin, Talbir Kaur

Abstract

The present invention relates to crystalline complexes of sulforaphane and alpha-cyclodextrin; pharmaceutical compositions comprising the complexes; methods for their manufacture; and the use of said complexes as a medicament.

IPC Classes  ?

  • A61P 35/00 - Antineoplastic agents
  • A61K 31/26 - Cyanate or isocyanate estersThiocyanate or isothiocyanate esters
  • A61K 47/69 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit